Cidara Therapeutics, Inc. (CDTX)
221.38
0.00 (0.00%)
USD |
NASDAQ |
Feb 06, 16:00
Cidara Therapeutics EPS Diluted (Quarterly) : -3.096 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| Johnson & Johnson | 2.098 |
| Bristol Myers Squibb Co. | 0.5326 |
| Pfizer Inc. | -0.2898 |
| Cogent Biosciences, Inc. | -0.5884 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -83.23M |
| Total Expenses (Quarterly) | 83.23M |
| Enterprise Value | 6.537B |
| Earnings Yield | -5.32% |
| Normalized Earnings Yield | -4.794 |